Mezion recently ranked among the top searched stocks on 2 days within the past month.
As of 12:30 PM on the 25th, Mezion is trading at 164,100 KRW, up 0.61% from the previous day. This is a 27.03% decrease compared to August 28. Mezion is known as a company specializing in new drug development.
Over the past 5 days, individual investors have net sold 1,555 shares, while foreigners and institutions have net sold 21,626 shares and net bought 22,604 shares, respectively.
On September 22, Mezion became a market topic with the announcement, "US FDA 'Udenafil' NDA supplementary documents submission completed, confident of final approval..."
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
